respiratori
system
consist
integr
network
organ
structur
primarili
function
ga
exchang
mammal
oxygen
carbon
dioxid
transmit
complex
respiratori
tract
consist
nasal
passag
pharynx
larynx
lung
exposur
ambient
air
throughout
lifespan
impos
vulner
respiratori
system
environment
challeng
contribut
toward
develop
diseas
import
respiratori
system
human
health
support
statist
center
diseas
control
prevent
chronic
lower
respiratori
diseas
third
lead
caus
death
unit
state
light
signific
mortal
associ
respiratori
condit
afflict
age
human
popul
review
focu
basic
preclin
research
conduct
nonhuman
primat
model
respiratori
diseas
comparison
laboratori
anim
nonhuman
primat
lung
close
resembl
human
lung
structur
physiolog
mucos
immun
mechan
studi
defin
influenc
inhal
microb
pollut
allergen
nonhuman
primat
lung
provid
insight
diseas
pathogenesi
potenti
elucid
molecular
target
lead
new
treatment
modal
vaccin
trial
nonhuman
primat
crucial
confirm
safeti
protect
efficaci
infecti
diseas
lung
laboratori
anim
model
recapitul
patholog
observ
human
look
futur
nonhuman
primat
model
respiratori
diseas
continu
instrument
translat
biomed
research
improv
human
health
mammalian
respiratori
system
consist
complex
seri
passageway
nasal
caviti
larynx
trachea
bronchi
transport
air
region
ga
exchang
alveoli
beyond
serv
conduit
respir
variou
region
lung
mucosa
equip
structur
hematopoiet
cell
popul
protect
function
overal
immun
within
individu
product
environ
whether
infecti
toxicolog
natur
often
elicit
protect
respons
respiratori
system
result
shortterm
morbid
chronic
diseas
understand
biolog
consequ
inhal
environment
challeng
well
effect
design
strategi
mitig
pulmonari
diseas
contribut
morbid
mortal
human
critic
conduct
basic
translat
research
laboratori
anim
model
close
recapitul
respiratori
tract
human
although
genet
modifi
rodent
continu
backbon
respiratori
diseas
research
nonhuman
primat
speci
essenti
understand
progress
pathogenesi
condit
initi
earli
life
moreov
immun
physiolog
paramet
nonhuman
primat
close
reflect
complex
human
system
cost
nonhuman
primat
research
may
prohibit
largescal
anim
experi
potenti
translat
human
clinic
trial
high
valu
follow
section
discuss
compar
anatomi
physiolog
nonhuman
primat
lung
rel
known
human
follow
overview
major
contribut
laboratori
anim
model
understand
inhal
toxicolog
chronic
airway
diseas
infecti
diseas
must
acknowledg
compar
anatomi
nonhuman
primat
lung
comprehens
summar
prior
public
plopper
harkema
plopper
hyde
import
goal
current
review
build
compar
anatomi
knowledg
base
translat
studi
expand
understand
airway
physiolog
respiratori
immun
primat
speci
human
well
small
larg
laboratori
mammal
speci
respiratori
tract
divid
bifurc
trachea
right
left
lung
review
plopper
harkema
human
rhesu
macaqu
monkey
macaca
mulatta
left
lung
divid
two
distinct
lobe
rhesu
monkey
right
lung
divid
four
lobe
wherea
human
right
lung
divid
three
lobe
comparison
rodent
left
lung
distinguish
individu
lobe
left
lung
four
distinct
lobe
right
lung
similar
nonhuman
primat
overal
lung
mass
rhesu
monkey
bodi
weight
comparison
approxim
bodi
weight
human
bodi
weight
mice
distinguish
featur
conduct
airway
anatomi
primat
speci
dichotom
symmetr
branch
upper
intralobar
airway
transit
alveolar
region
via
sever
gener
thinwal
noncartilagin
bronchiol
contain
outpocket
alveoli
respiratori
bronchiol
respiratori
bronchiol
observ
rodent
speci
branch
pattern
monopodi
result
significantli
differ
deposit
profil
inhal
materi
one
featur
common
primat
rodent
speci
high
rate
particl
deposit
anatom
region
transit
air
conduct
ga
exchang
whether
respiratori
bronchiol
primat
centriacinar
region
rodent
howev
cell
popul
locat
transit
conduct
airway
ga
exchang
consist
mixtur
ciliat
club
alveolar
epitheli
cell
primat
vs
distinct
separ
bronchiolar
cell
alveolar
epitheli
cell
rodent
unknown
differ
epitheli
cell
complex
contribut
speci
distinct
biolog
respons
environment
challeng
manifest
small
airway
diseas
respiratori
bronchiol
respons
infect
bronchiol
obliteran
follow
transplant
uncommon
primat
speci
review
burgel
et
al
cellular
level
conduct
airway
tree
lung
display
speciesdepend
differ
compar
rang
laboratori
anim
model
trachea
midlevel
intralobar
airway
overli
epithelia
mixtur
ciliat
mucou
basal
cell
along
extens
submucos
gland
mucosa
conduct
airway
primat
speci
substanti
proxim
trachea
distal
intralobar
region
contain
cartilag
extens
smooth
muscl
comparison
epitheli
line
rodent
conduct
airway
tree
predominantli
popul
club
cell
ciliat
cell
minim
amount
lamina
propria
contain
small
number
smooth
muscl
fiber
individu
cellular
constitu
contribut
structur
lung
play
import
role
mani
differ
acut
chronic
respiratori
diseas
emphas
need
conduct
basic
translat
studi
nonhuman
primat
defin
mechan
promot
patholog
human
exampl
comparison
airway
transcriptom
rhesu
macaqu
model
mous
model
hous
dust
miteinduc
asthma
show
significantli
greater
overlap
gene
profil
monkey
lung
biopsi
obtain
human
asthma
patient
abba
et
al
identifi
mechan
factor
within
pulmonari
system
contribut
ventilatori
dysfunct
critic
understand
ultim
treat
underli
caus
chronic
airway
diseas
moreov
mechan
chang
lung
respons
perturb
indic
diagnost
diseas
statu
size
nonhuman
primat
commonli
use
biomed
research
permit
character
pulmonari
diseas
process
util
techniqu
common
studi
human
pulmonari
diseas
pulmonari
function
test
util
nonhuman
primat
research
cours
sever
decad
initi
studi
measur
lung
volum
capac
pulmonari
mechan
variabl
nonhuman
primat
rel
descript
natur
import
provid
basi
expect
valu
rhesu
monkey
chest
wall
rel
stiff
comparison
small
domest
anim
similar
human
chest
wall
featur
primat
anatomi
physiolog
give
rise
relax
lung
volum
known
function
residu
capac
compris
larg
percentag
total
lung
capac
koik
et
al
pare
et
al
dynam
flow
paramet
similar
forc
expiratori
volum
commonli
use
human
patient
also
measur
nonhuman
primat
found
similar
dog
larger
human
normal
lung
size
kosch
et
al
common
method
mechan
character
reli
simpl
model
pulmonari
system
give
pulmonari
resist
dynam
complianc
complex
method
hold
promis
extens
character
pulmonari
mechan
function
minim
invas
forc
oscillometri
gain
popular
human
patient
especi
perform
maneuv
compris
common
pulmonari
function
test
forc
oscillometri
techniqu
develop
mani
year
monkey
includ
part
evalu
process
duboi
et
al
wegner
et
al
use
model
system
allow
separ
complianc
airway
resist
tissu
resist
cynomolgu
macaqu
monkey
macaca
fasiculari
found
respond
bronchoact
agent
primarili
chang
airway
resist
indic
larg
airway
contribut
frequenc
depend
respons
suggest
heterogen
constrict
black
et
al
madw
jackson
studi
monkey
suggest
peripher
airway
contribut
onethird
lung
resist
respons
bronchoact
agent
pare
et
al
given
avail
techniqu
enabl
identif
peripher
airway
dysfunct
heterogen
ventil
addit
standard
paramet
fidel
nonhuman
primat
lung
develop
anatomi
human
laboratori
anim
model
particularli
relev
studi
pulmonari
diseas
process
human
especi
small
airway
play
signific
role
shaw
et
al
ozon
ozon
major
constitu
photochem
air
pollut
acut
chronic
inhal
studi
nonhuman
primat
play
critic
role
defin
ozoneinduc
injuri
inflammatori
repair
respons
recent
nonhuman
primat
studi
focus
effect
earlylif
ozon
exposur
lung
develop
numer
studi
demonstr
ozoneinduc
lesion
inflamm
conduct
airway
rhesu
monkey
bonnet
macaqu
monkey
macaca
radiata
expos
ozon
concentr
ppm
period
hour
day
castleman
et
al
castleman
et
al
castleman
et
al
dungworth
et
al
mellick
et
al
gradient
damag
larg
bronchi
greatest
damag
distal
bronchiol
least
observ
nonhuman
primat
expos
high
ambient
concentr
ozon
ppm
hoursday
day
castleman
et
al
expos
bonnet
monkey
ppm
ozon
hoursday
day
observ
alter
cilia
increas
noncili
cell
castleman
et
al
sever
damag
involv
largest
number
ciliat
cell
locat
trachea
proxim
bronchi
less
extens
chang
present
distal
bronchi
respiratori
bronchiol
consist
observ
subacut
exposur
studi
use
nonhuman
primat
surfac
alter
view
scan
electron
microscopi
consist
randomli
scatter
patch
longitudin
tract
number
day
ozon
exposur
extend
beyond
day
lesion
trachea
proxim
bronchi
recov
epithelium
larg
conduct
airway
becom
rel
insensit
continu
exposur
wilson
et
al
contrast
monkey
expos
ppm
ozon
day
hour
per
day
signific
nasal
epitheli
lesion
ciliat
cell
necrosi
attenu
cilia
secretori
cell
hyperplasia
bronchiol
consist
hyperplasia
hypertrophi
noncili
bronchiolar
epitheli
cell
thicken
interstitium
intralumin
accumul
macrophag
harkema
et
al
harkema
et
al
develop
chronic
bronchiol
prolong
month
exposur
high
ambient
concentr
ozon
demonstr
multipl
nonhuman
primat
studi
eusti
et
al
fujinaka
et
al
harkema
et
al
tyler
et
al
tyler
et
al
expos
young
nonhuman
primat
ppm
continu
episod
everi
month
month
observ
despit
deliv
onehalf
ozon
dose
episod
exposur
produc
larger
biochem
physiolog
alter
equival
morphometr
chang
tyler
et
al
examin
effect
earlylif
ozon
exposur
lung
develop
old
infant
rhesu
macaqu
expos
episod
day
hoursday
ppm
follow
day
filter
air
compar
control
infant
ozoneexpos
anim
reduc
epitheli
innerv
four
fewer
nonalveolar
airway
gener
hyperplast
bronchiolar
epithelium
alter
smooth
muscl
bundl
orient
termin
respiratori
bronchiol
increas
alveolar
number
fanucchi
et
al
larson
et
al
chang
associ
alter
serotonin
substanc
p
fibroblast
growth
factor
signal
conduct
airway
moor
et
al
murphi
et
al
murphi
et
al
cessat
exposur
month
result
normal
fibroblast
growth
factor
signal
epitheli
hyperinnerv
airway
serotonin
signal
remain
alter
long
follow
end
exposur
kajekar
et
al
moor
et
al
total
studi
earlylif
episod
ozon
exposur
provid
evid
prolong
structur
function
airway
chang
could
increas
risk
chronic
lung
diseas
anim
age
exposur
tobacco
smoke
major
contributor
cardiopulmonari
diseas
irrit
chronic
inflamm
airway
alveoli
lead
myriad
condit
includ
bronchiti
chronic
obstruct
pulmonari
diseas
copd
emphysema
well
multipl
form
benign
malign
lung
cancer
accord
world
health
organ
copd
fourth
lead
caus
death
world
today
exposur
tobacco
smoke
either
activ
passiv
repres
prevent
type
lung
diseas
known
smoke
cessat
regul
nonhuman
primat
key
advanc
understand
mechan
smokeinduc
lung
diseas
due
earlylif
exposur
secondhand
smoke
also
known
environment
tobacco
smoke
earlylif
exposur
secondhand
smoke
signific
consequ
normal
develop
wide
varieti
organ
system
particular
respiratori
system
exposur
low
level
environment
tobacco
smoke
mgm
pregnanc
begin
gestat
day
first
month
postnat
life
downregul
nfkappabdepend
antiapoptot
gene
induc
activ
caspas
cleavag
cellular
death
substrat
poli
adp
ribos
polymeras
caspaseactiv
dnase
thu
increas
rate
apoptosi
neonat
lung
parenchyma
event
directli
compromis
normal
cell
prolifer
potenti
impair
normal
lung
growth
function
earli
life
zhong
et
al
exposur
environment
tobacco
smoke
earli
life
nonhuman
primat
also
enhanc
local
h
immun
impair
normal
pulmonari
h
immun
matur
effect
greater
anim
begin
environment
tobacco
smoke
et
exposur
utero
contrast
infant
expos
postnat
neonat
monkey
expos
utero
first
month
postnat
life
demonstr
signific
downregul
mrna
ifngamma
ifngammainduc
protein
monokin
induc
ifngamma
ifngammainduc
tcell
chemoattract
cxc
chemokin
receptor
bioactiv
subunit
tbet
contrast
infant
monkey
expos
postnat
life
month
age
et
show
signific
downregul
ifngamma
cxc
chemokin
receptor
level
mrna
thymu
activationregul
chemokin
increas
protein
reduc
wang
et
al
perinat
et
exposur
monkey
induc
system
local
respons
signific
elev
plasma
level
brainderiv
neurotroph
factor
well
signific
increas
express
proinflammatori
cytokin
tnfalpha
h
cytokin
chemokin
monocyt
chemoattract
protein
lung
along
signific
increas
presenc
substanc
pposit
nerv
along
bronchial
airway
innerv
epitheli
line
lung
perinat
et
exposur
also
significantli
increas
number
mast
cell
eosinophil
monocyt
lymphocyt
lung
infant
monkey
yu
et
al
perinat
exposur
et
also
induc
acut
system
inflammatori
respons
nonhuman
primat
significantli
alter
varieti
immun
effector
fetal
postnat
exposur
et
found
alter
normal
matur
mrna
level
ifngamma
well
ratio
lymphocyt
compar
filteredair
control
level
blood
lymphocyt
subset
distribut
also
found
significantli
differ
base
time
onset
exposur
et
earli
life
even
shortterm
exposur
et
week
postnat
infant
monkey
found
significantli
increas
level
peripher
blood
neutrophil
mrna
find
suggest
normal
immun
system
develop
significantli
compromis
utero
postnat
exposur
et
contribut
etsrel
childhood
diseas
wang
et
al
ozon
tobacco
smoke
wellstudi
environment
exposur
nonhuman
primat
model
like
due
strong
associ
common
air
pollut
chronic
respiratori
diseas
human
asthma
copd
limit
data
avail
inhal
toxicolog
studi
nonhuman
primat
occup
exposur
chlorin
ga
formaldehyd
ga
evalu
chronic
model
rhesu
macaqu
elicit
significantli
differ
patholog
compar
rat
model
klonn
et
al
monticello
et
al
carcinogen
longterm
diesel
coal
dust
exposur
examin
cynomolgu
monkey
comparison
rat
monkey
show
minim
evid
cellular
abnorm
lewi
et
al
similar
find
observ
followup
studi
cynomolgu
monkey
expos
asbesto
stettler
et
al
despit
pervas
particul
matter
environ
known
report
experiment
exposur
airborn
product
combust
nonhuman
primat
model
recent
cohort
outdoorh
adolesc
rhesu
macaqu
monkey
expos
ambient
wildfir
smoke
high
sourc
evalu
lung
function
immun
profil
anim
expos
infanc
display
reduc
lung
volum
dysregul
innat
immun
suggest
longterm
health
impact
inhal
particul
matter
earli
life
black
et
al
electron
cigarett
use
tripl
among
middl
high
schoolag
children
arrazola
et
al
adolesc
perceiv
electron
cigarett
safer
tradit
cigarett
result
use
expand
individu
may
use
tradit
cigarett
barringtontrimi
et
al
cigarett
smoke
overrepres
adolesc
psychiatr
disord
ecigarett
use
extend
emot
healthier
subset
expand
use
beyond
would
use
tradit
cigarett
leventh
et
al
upadhyaya
et
al
epidemiolog
estim
indic
electron
cigarett
vapor
ecv
carri
risk
asthma
young
peopl
wherea
may
earli
estim
risk
copd
ecv
use
minut
healthi
smoker
elicit
pulmonari
function
deficit
similar
smoke
cho
paik
vardava
et
al
perceiv
safe
altern
tradit
cigarett
current
evid
indic
ecigarett
contribut
lung
diseas
nonhuman
primat
model
would
wellposit
directli
assess
acut
chronic
effect
inhal
exposur
adolesc
popul
complex
behavior
pattern
exhibit
monkey
also
associ
pulmonari
dysfunct
may
coupl
exposur
ecv
exacerb
pulmonari
diseas
process
point
monkey
model
optim
discoveri
process
asthma
advent
pulmonari
function
test
techniqu
nonhuman
primat
investig
began
character
cynomolgu
monkey
natur
infect
nematod
ascari
suum
show
allerg
reaction
suum
antigen
patterson
talbot
model
prove
good
represent
human
atop
asthma
becam
wide
use
pharmaceut
industri
help
character
allerg
airway
diseas
gundel
et
al
krell
et
al
osborn
et
al
turner
et
al
young
et
al
acut
allerg
airway
respons
monkey
found
primarili
mediat
histamin
cysteinyl
leukotrien
osborn
et
al
rel
potenc
cysteinyl
leukotrien
cyslt
compar
histamin
variabl
studi
may
region
speciesspecif
effect
inhal
cyslt
monkey
mimic
asthmat
phenotyp
johnson
et
al
krell
et
al
seehas
et
al
reaction
cyslt
monkey
appear
mediat
cholinerg
reflex
airway
wherea
parenchym
respons
show
less
respons
cholinerg
inhibit
atropin
johnson
et
al
monkey
model
also
reveal
respond
display
latephas
respons
similar
asthmat
latephas
airway
obstruct
tie
neutrophil
influx
prime
presenc
eosinophil
airway
inhibit
block
endotheli
leukocyt
adhes
molecul
gundel
et
al
gundel
et
al
natur
model
suum
asthma
given
way
model
util
activ
sensit
number
differ
allergen
common
human
allergen
hous
dust
mite
first
nonhuman
primat
model
experiment
induc
asthma
use
hous
dust
mite
dermatophagoid
farin
rhesu
monkey
report
subsequ
replic
investig
use
cynomolgu
monkey
schelegl
et
al
van
scott
et
al
rhesu
monkey
period
chronic
aerosol
challeng
hous
dust
mite
result
multipl
paramet
clinic
asthma
human
includ
eosinophil
inflamm
lung
remodel
conduct
airway
enhanc
physiolog
reactiv
nonspecif
stimuli
methacholin
schelegl
et
al
rhesu
model
hous
dust
miteinduc
atop
asthma
util
preclin
trial
asthma
therapeut
seshasaye
et
al
infant
rhesu
monkey
model
childhood
asthma
combin
adjuv
properti
ozon
hous
dust
mite
exposur
also
report
inhal
corticosteroid
treatment
infant
monkey
display
asthma
phenotyp
result
attenu
symptom
also
alter
normal
lung
growth
schelegl
et
al
copd
associ
cigarett
smoke
studi
attempt
model
copd
exposur
monkey
tobacco
smoke
earli
studi
train
baboon
smoke
assess
pack
year
smoke
common
metric
copd
studi
indic
product
averag
pack
per
day
smoke
year
smoke
interestingli
bronchial
reactiv
blunt
residu
lung
volum
preserv
upon
exposur
cholinerg
agonist
methacholin
smoke
monkey
roehr
et
al
inhal
nicotin
found
mediat
blunt
methacholin
respons
affect
baselin
lung
function
wherea
respons
histamin
unaffect
walli
et
al
recent
examin
heavi
smoke
approxim
packsday
cynomolgu
monkey
cours
week
provid
insight
patholog
process
monkey
model
week
pulmonari
function
chang
show
minim
differ
sham
exposur
trend
toward
reduc
fev
patholog
chang
pronounc
inflamm
mucu
metaplasia
glandular
hypertrophyhyperplasia
peribronchi
fibrosi
evid
addit
preemphysemet
profil
indic
elev
matrix
apoptosi
alveolar
septal
cell
elev
oxid
stress
lung
tissu
polverino
et
al
use
approach
recent
report
combin
cigarett
smoke
influenza
infect
increas
connect
tissu
growth
factor
could
acceler
epitheli
cell
senesc
jang
et
al
line
continu
interest
person
medicin
biomed
research
commun
major
push
phenotyp
human
asthma
copd
subject
use
molecular
marker
base
multipl
paramet
clinic
sever
one
categori
human
patient
popul
proven
experiment
challeng
replic
anim
model
nonatop
intrins
asthmat
date
littl
known
regard
underli
mechan
elicit
nonatop
asthma
beyond
elev
bodi
mass
index
increas
serum
fahi
peter
et
al
retrospect
studi
capitanio
colleagu
report
behavior
inhibit
tempera
rhesu
monkey
may
predict
intrins
airway
hyperrespons
nonspecif
challeng
find
subsequ
replic
prospect
studi
capitanio
et
al
chun
et
al
underli
pulmonari
function
deficit
associ
airway
hyperrespons
determin
natur
model
nonatop
asthma
royer
et
al
studi
investig
immun
genet
basi
phenotyp
conduct
futur
nonhuman
primat
long
serv
laboratori
anim
model
infecti
diseas
human
lung
primari
site
infect
manifest
ill
comparison
laboratori
anim
rodent
canin
speci
immun
system
nonhuman
primat
show
signific
homolog
human
critic
characterist
understand
hostpathogen
respons
lead
identif
therapeut
target
messaoudi
et
al
similar
immun
mechan
nonhuman
primat
model
respiratori
infect
provid
critic
biomed
resourc
acceler
preliminari
safeti
efficaci
test
vaccin
well
pharmaceut
intervent
ethic
evalu
human
subject
prior
clinic
trial
global
scale
pathogen
target
respiratori
system
particular
concern
human
health
due
possibl
airborn
transmiss
lead
rapid
dissemin
infect
via
intern
travel
complex
mechan
use
certain
pathogen
respiratori
tract
evad
immun
system
host
contribut
slow
increment
success
identifi
cellular
pathway
may
target
drug
vaccin
develop
recent
experiment
studi
nonhuman
primat
model
focus
respiratori
virus
evolv
domest
wild
anim
host
along
continu
effort
prevent
establish
respiratori
infecti
diseas
human
popul
use
novel
vaccin
method
fungal
bacteri
respiratori
infect
also
investig
nonhuman
primat
model
primarili
context
secondari
opportunist
pathogen
immunocompromis
host
highlight
nonhuman
primat
infect
model
common
virus
microb
target
respiratori
tract
emphasi
clinic
treatment
prevent
strategi
may
translat
human
popul
estim
world
health
organ
million
peopl
die
year
tuberculosi
tb
million
individu
becom
newli
infect
year
review
zumla
et
al
despit
known
exist
diseas
sinc
remain
one
top
caus
death
worldwid
make
search
effect
vaccin
drug
elicit
resist
mycobacterium
prioriti
one
oldest
experiment
nonhuman
primat
model
human
respiratori
pathogen
infect
develop
address
imperfect
murin
model
mycobacterium
tuberculosi
caus
agent
tb
human
major
first
step
establish
nonhuman
primat
model
tb
report
walsh
et
al
cynomolgu
monkey
use
demonstr
feasibl
infect
intratrach
administr
either
high
low
dose
tuberculosi
high
dose
tuberculosi
elicit
fulmin
condit
low
dose
result
chronic
symptom
similar
describ
human
patient
walsh
et
al
cynomolgu
model
subsequ
refin
capuano
et
al
use
bronchoscopi
lowdos
instil
tuberculosi
follow
longterm
immun
clinic
monitor
anim
result
cohort
display
spectrum
patholog
condit
observ
human
popul
earli
bacillu
calmetteguerin
bcg
vaccin
prevent
tb
develop
use
weaken
strain
bovin
mycobacterium
bovi
current
still
use
mani
countri
efficaci
bcg
prevent
develop
tb
highli
variabl
colditz
et
al
find
human
epidemiolog
born
experiment
nonhuman
primat
studi
rhesu
macaqu
monkey
model
experiment
tb
clearli
support
observ
limit
efficaci
bcg
vaccin
langerman
et
al
numer
attempt
use
innov
vaccin
approach
fail
howev
recent
mucos
aerosol
studi
tuberculosi
strain
engin
mutant
sigh
region
effect
protect
rhesu
macaqu
lethal
tb
challeng
suggest
human
clinic
trial
immin
kaushal
et
al
addit
serv
critic
laboratori
anim
model
human
tb
nonhuman
primat
critic
develop
blood
diagnost
detect
interferon
product
respons
tuberculosi
step
virtual
elimin
need
less
sensit
specif
tuberculin
skin
test
garcia
et
al
measl
diseas
result
infect
measl
viru
classifi
rna
viru
within
genu
morbilliviru
paramyxovirida
famili
measl
viru
highli
contagi
readili
spread
airborn
transmiss
follow
infect
within
respiratori
tract
infect
measl
viru
result
signific
morbid
immunosuppress
lead
enhanc
suscept
mortal
childhood
infecti
diseas
mina
et
al
despit
avail
effect
vaccin
sinc
earli
resourcepoor
countri
recent
spate
antivaccin
propon
contribut
dramat
increas
outbreak
global
within
unit
state
necessit
investig
robust
vaccin
strategi
enhanc
gap
immun
durrheim
gastanaduy
et
al
mulholland
et
al
nonhuman
primat
highli
suscept
infect
measl
viru
experiment
inocul
result
acut
clinic
sign
compar
observ
human
kobun
et
al
surprisingli
littl
known
cellular
molecular
mechan
measl
viru
elicit
patholog
respiratori
tract
long
known
primari
sourc
viral
particl
assum
epitheli
cell
primari
target
despit
lack
express
known
high
affin
receptor
viral
entri
erlenhoef
et
al
eleg
studi
cynomolgu
macaqu
use
recombin
green
fluoresc
protein
label
measl
viru
clearli
demonstr
alveolar
macrophag
dendrit
cell
initi
site
viral
replic
follow
spread
lymphoid
aggreg
oral
caviti
lemon
et
al
ludlow
et
al
recent
preferenti
target
antigenpres
cell
measl
viru
support
im
inocul
liveattenu
viru
cynomolgu
macaqu
rennick
et
al
innov
approach
achiev
high
coverag
vaccin
also
develop
nonhuman
primat
model
measl
includ
use
microneedl
patch
requir
inject
eden
et
al
influenza
respiratori
diseas
caus
infect
either
influenza
b
viru
strain
rna
virus
orthomyxoviru
famili
contrast
season
influenza
infect
pandem
influenza
viru
strain
signific
concern
human
health
due
limit
immun
global
scale
result
complic
requir
hospit
mortal
atrisk
popul
experiment
anim
model
viral
infect
use
nonhuman
primat
play
essenti
role
understand
pathogenesi
pandem
influenza
strain
well
highli
pathogen
strain
avian
davi
et
al
mechanist
perspect
nonhuman
primat
particularli
import
defin
immunomodulatori
pathway
dictat
health
outcom
vulner
popul
weaken
immun
toward
vaccin
prepar
young
children
geriatr
individu
asquith
et
al
clay
et
al
holbrook
et
al
surprisingli
infant
rhesu
macaqu
african
green
monkey
suscept
viru
reveal
delay
type
interferon
synthesi
impair
mucos
immunoglobulin
respons
follow
infect
season
influenza
vaccin
recommend
children
age
month
target
popul
vulner
hospit
mortal
due
infect
major
emphasi
nonhuman
primat
model
influenza
infect
investig
vaccin
adjuv
enhanc
immunogen
vulner
popul
date
inclus
adjuv
flagellin
appear
modest
efficaci
pediatr
infect
model
result
enhanc
paramet
humer
immun
holbrook
et
al
holbrook
et
al
howev
cation
lipiddna
complex
shown
dramat
reduc
viral
replic
follow
vaccin
trival
inactiv
influenza
vaccin
geriatr
anim
challeng
carrol
et
al
infect
respiratori
syncyti
viru
rna
viru
paramyxovirid
famili
one
common
respiratori
infect
earli
life
estim
children
infect
review
meissner
popul
infanc
geriatr
vulner
infect
respiratori
syncyti
viru
infant
particularli
suscept
develop
viral
bronchiol
often
requir
hospit
moreov
childhood
infect
respiratori
syncyti
viru
frequent
predictor
develop
asthma
later
life
jackson
et
al
sever
nonhuman
primat
speci
util
model
respiratori
syncyti
viru
infect
includ
rhesu
macaqu
bonnet
monkey
macaca
radiata
baboon
de
swart
et
al
mcarthurvaughan
gershwin
papin
et
al
simo
et
al
vaccin
trial
respiratori
syncyti
viru
proceed
caution
follow
sever
death
result
earli
trial
use
formalin
inactiv
viru
subsequ
test
nonhuman
primat
show
viral
challeng
elicit
hypersensit
reaction
de
swart
et
al
date
safe
effect
vaccin
respiratori
syncyti
viru
highrisk
infant
may
receiv
prophylaxi
form
human
monoclon
antibodi
target
viral
surfac
protein
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
pulmonari
diseas
caus
infect
member
coronovirida
famili
singlestrand
rna
virus
outbreak
either
sar
mer
rel
isol
result
sever
diseas
mortal
suscept
popul
first
report
outbreak
sar
confirm
sar
coronaviru
etiolog
agent
diseas
determin
infect
rhesu
macaqu
monkey
result
symptom
compar
human
infect
row
et
al
studi
african
green
monkey
establish
immun
defici
associ
age
process
result
enhanc
morbid
follow
infect
sar
coronaviru
clay
et
al
first
known
report
mer
took
place
addit
case
emerg
within
middl
eastern
region
arabi
et
al
mer
coronaviru
infect
rhesu
macaqu
common
marmoset
callithrix
jacchu
result
clinic
symptom
marmoset
report
develop
lethal
pneumonia
follow
infect
falzarano
et
al
yao
et
al
fungu
pneumocysti
jirovecii
abund
within
environ
highli
pathogen
immunocompromis
human
result
lifethreaten
pneumonia
pneumocysti
pneumonia
frequent
associ
human
immunodefici
viru
infect
howev
individu
undergo
chemotherapi
suscept
popul
infant
geriatr
also
vulner
infect
review
edden
koll
confirm
role
immun
compromis
pathogenesi
pneumocysti
pneumonia
experiment
determin
macaqu
model
human
immunodefici
viru
infect
use
simian
immunodefici
viru
siv
board
et
al
subsequ
shown
humer
immun
p
jirovecii
proteas
kexin
protein
strongli
link
health
outcom
sivinfect
monkey
corollari
human
patient
kling
et
al
vaccin
recombin
peptid
result
protect
humer
immun
p
jirovecii
infect
even
immunosuppress
sivinfect
monkey
kling
norri
similar
fungal
pneumonia
suscept
popul
also
risk
develop
bacteri
pneumonia
estim
streptococcu
pneumonia
contribut
approxim
death
children
worldwid
obrien
et
al
late
model
pneumonia
klebsiella
pneumonia
initi
describ
squirrel
monkey
saimiri
sciureu
contrast
rodent
model
elicit
lobar
pneumonia
compar
human
berendt
et
al
berendt
et
al
rhesu
macaqu
model
pneumonia
infect
subsequ
develop
success
use
evalu
novel
proteinbas
pneumococc
vaccin
denoel
et
al
philipp
et
al
recent
sever
pneumonia
model
describ
adult
baboon
papio
cynocephalu
primarili
purpos
identifi
new
biomark
earli
stage
infect
goal
rapid
diagnosi
treatment
kraft
et
al
rey
et
al
whoop
cough
acut
respiratori
ill
childhood
result
infect
bordatella
pertussi
highli
contagi
gramneg
bacterium
block
normal
mucociliari
clearanc
lung
product
cytotoxin
vaccin
b
pertussi
avail
sinc
acellular
form
conjunct
diphtheria
tetanu
incorpor
part
routin
childhood
immun
schedul
decad
review
kilgor
et
al
incid
whoop
cough
steadili
increas
year
epidemiolog
report
implic
wane
immun
adolesc
contribut
outbreak
unit
state
klein
et
al
better
understand
immun
basi
declin
immun
juvenil
multipl
speci
nonhuman
primat
evalu
anim
model
b
pertussi
taiwanes
macaqu
macaca
cyclopi
may
becom
infect
b
pertussi
develop
clinic
symptom
howev
avail
speci
research
limit
consid
endang
huang
et
al
contrast
taiwanes
macaqu
approxim
rhesu
macaqu
monkey
infect
b
pertussi
display
clinic
symptom
consist
human
diseas
warfel
et
al
baboon
appear
much
reliabl
nonhuman
primat
infect
model
b
pertussi
recent
yield
import
immunolog
insight
mechan
diminish
vaccin
potenc
human
popul
infect
baboon
b
pertussi
vaccin
whole
pertussi
result
longlast
immun
howev
current
use
acellular
pertussi
vaccin
elicit
mix
immun
suggest
cell
effector
mechan
may
critic
robust
diseas
protect
warfel
merkel
warfel
et
al
recent
studi
baboon
model
evalu
prophylact
efficaci
human
pertussisneutr
antibodi
cocktail
adjuv
tradit
antibiot
treatment
follow
b
pertussi
infect
nguyen
et
al
within
past
two
decad
sever
respiratori
virus
emerg
anim
reservoir
infect
unprepar
human
popul
densiti
human
popul
increas
worldwid
almost
unlimit
capac
global
travel
outbreak
continu
take
place
capac
respiratori
pathogen
precipit
impos
catastroph
diseas
human
popul
necessit
continu
biomed
research
investig
novel
chemic
inhibitor
microbi
growth
biolog
reduc
lifethreaten
acut
inflamm
vaccin
nonhuman
primat
lung
immun
system
close
recapitul
human
remain
reliant
essenti
laboratori
anim
model
assess
pathogenesi
infecti
agent
efficaci
therapeut
futur
despit
signific
progress
develop
robust
nonhuman
primat
model
respiratori
diseas
past
sever
decad
viabl
pharmaceut
candid
perman
restor
lung
function
mucos
immun
remain
elus
compar
aspect
nonhuman
primat
lung
anatomi
physiolog
immunolog
reinforc
necess
conduct
pharmaceut
studi
laboratori
anim
model
prolong
natur
chronic
respiratori
condit
present
major
obstacl
conduct
experiment
investig
speci
practic
manner
address
challeng
expand
use
new
world
monkey
speci
acceler
lifespan
eg
marmoset
may
ultim
key
success
potenti
yield
critic
inform
natur
progress
obstruct
airway
lung
function
declin
human
popul
